GET THE APP

Ventricular Fibrillation Innovations | Open Access Journals
Journal of Cosmetology & Trichology

Journal of Cosmetology & Trichology

ISSN: 2471-9323

Open Access

Ventricular Fibrillation Innovations

Ventricular tachycardia (VT) is a crucial cause of sudden cardiac death (SCD) and a leading cause of death and morbidity in patients with structural heart disease. TV includes clinical conditions ranging from mild to life-threatening. Most life-threatening episodes are correlated with coronary artery disease, but the risk of SCD varies in some populations, with various underlying heart conditions, specific family history, and genetic variants. The goals of managing VT are to alleviate symptoms, improve quality of life, reduce shock from implantable cardioverter defibrillator, prevent reduction in left ventricular function, reduce the risk of SCD and improving overall survival. Antiarrhythmic  drug therapy and endocardial catheter ablation remain the cornerstone of guidelines-approved strategies for treating VT in patients with structural heart abnormalities. New strategies such as epicardial ablation, surgical cryoablation, transcoronary alcohol ablation, preoperative imaging and stereotaxic ablative radiotherapy are an attractive area of   research. In this review, we have collected all recent advances in innovative therapies as well as experimental evidence focusing on different aspects of the treatment of VT that may be significant for future favorable clinical applications.

Although treatment for heart failure reduces mortality and SCD, it has failed to reduce recurrences of ventricular tachycardia (VT) . Implantable cardioverter defibrillators (ICDs) are very effective in eliminating episodes of VT and in reducing the possibility of SCD, but they are not useful for the prevention of arrhythmia. When the TV substrate manifests, anti-arrhythmic drug therapy or catheter ablation are the current choices for reducing TV episodes . Catheter ablation and antiarrhythmic  drug therapy are however limited by incomplete efficacy, unfavorable side effects and procedural risk . In this review, we describe current advances in VT treatment options and describe the imaging modalities, progress and new strategies.

High Impact List of Articles
Conference Proceedings

Relevant Topics in Clinical Sciences

arrow_upward arrow_upward